Trial Profile
Study of Oxaliplatin and Taxotere in Androgen Independent Prostate Cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Docetaxel (Primary) ; Oxaliplatin (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- 19 Jan 2012 Additional lead trial investigator (Leonard J Appleman) identified as reported by ClinicalTrials.gov.
- 19 Jan 2012 Actual patient number (34) added as reported by ClinicalTrials.gov.
- 19 Jan 2012 Actual end date (1 Sep 2007 ) added as reported by ClinicalTrials.goc.